ArticleRegenerative therapy2026
Kidney organoid vascularization: current advancements in the field.
Article in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney organoids have the possibility to vastly advance renal medicine, both as an organ model and as a cell source for regenerative medicine. While significant improvements have been made in recreating organ specific lineages, one area that still demands improvement is vascularization. Specifically, glomerular vascularization, an indispensable factor for renal function, has seldom been achieved in vitro. In this review, we summarize current research on this field. We first outline the contemporary understanding of renal development, as well as its implications on kidney organoid vascularization. Two important aspects warrant particular attention; the origin of endothelial cells during vascularization, and the mechanisms of glomerular vascularization. We then present the diverse strategies that aim for kidney organoid vascularization, both in vivo and in vitro. While in vivo approaches have been better in achieving glomerular vascularization, a few reports have been successful in vascularizing glomeruli in vitro by utilizing conditions such as flow, and endothelial niche induction. Finally, we introduce fields of research that could potentially be integrated to further improve vascularization and maturation. These include methods such as focusing on endothelial cell phenotypes as was done in vascularization of other organoid types, introduction of non-parenchymal cell types, and general scale-up of production, culture, and analysis of kidney organoids.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.